Autoimmune Diseases
Information
- Disease name
- Autoimmune Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03843034 | Active, not recruiting | Endometrial Markers in Autoimmune Diseases | February 18, 2019 | December 31, 2023 | |
| NCT05445284 | Active, not recruiting | N/A | Group Education Trial to Improve Transition for Parents of Adolescents With T1D | October 10, 2023 | March 2026 |
| NCT04593888 | Active, not recruiting | N/A | Gluten Reduction and Risk of Celiac Disease | May 5, 2021 | December 31, 2035 |
| NCT06202612 | Active, not recruiting | Phase 1 | A SHR0302 BA Study on Healthy Subjects | January 16, 2024 | May 2024 |
| NCT01351805 | Active, not recruiting | N/A | Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | July 2010 | February 2025 |
| NCT04663204 | Active, not recruiting | Phase 2 | A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy | December 10, 2020 | March 31, 2025 |
| NCT05516758 | Active, not recruiting | Phase 2 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis | August 31, 2022 | January 23, 2025 |
| NCT03147937 | Active, not recruiting | Cognitive Changes After Major Joint Replacement - Full Trial (Cognigram 2) | May 1, 2017 | December 2024 | |
| NCT03562975 | Active, not recruiting | Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus | July 23, 2018 | December 2023 | |
| NCT00001291 | Completed | Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions | December 1991 | January 2001 | |
| NCT00817752 | Completed | Phase 1 | Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation | May 2007 | February 2008 |
| NCT00820469 | Completed | Phase 4 | Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab | September 2008 | January 2010 |
| NCT06035614 | Completed | N/A | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children | October 1, 2022 | July 1, 2023 |
| NCT00975936 | Completed | Phase 1 | Phase 0 Microdose Study | September 21, 2009 | November 12, 2009 |
| NCT01004432 | Completed | Phase 3 | Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) | December 2009 | October 2013 |
| NCT01056471 | Completed | Phase 1/Phase 2 | Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis | January 2010 | June 2015 |
| NCT01065285 | Completed | Phase 4 | Vaccination Against Influenza in Autoimmune Diseases | October 2009 | February 2012 |
| NCT01093911 | Completed | Phase 1 | Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) | March 2010 | December 2012 |
| NCT01180868 | Completed | The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases | May 2008 | ||
| NCT01210716 | Completed | Phase 3 | Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device | September 2010 | May 2011 |
| NCT05966350 | Completed | Anti-Argonaute Antibodies for the Diagnosis of Sensory Neuronopathies | May 27, 2021 | January 27, 2023 | |
| NCT01416350 | Completed | Phase 1 | A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin | March 30, 2011 | May 12, 2011 |
| NCT01420133 | Completed | N/A | Is a Diet Necessary When Corticosteroid Treatment is Prescribed? | November 2011 | October 2015 |
| NCT05841719 | Completed | N/A | Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study. | April 22, 2023 | January 1, 2024 |
| NCT01582880 | Completed | Phase 1/Phase 2 | Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis | March 2012 | March 2014 |
| NCT01601028 | Completed | Phase 3 | Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome | July 2011 | August 2013 |
| NCT01611636 | Completed | Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study | January 1, 2012 | December 30, 2019 | |
| NCT01656278 | Completed | N/A | An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis | March 2012 | May 2017 |
| NCT01727973 | Completed | Phase 1/Phase 2 | Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy | October 2012 | November 2013 |
| NCT05807971 | Completed | Phase 1 | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects | April 6, 2023 | February 8, 2024 |
| NCT01758250 | Completed | Microvascular and Fibrosis Imaging Study | February 2013 | February 2018 | |
| NCT01764594 | Completed | Phase 1 | Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus | January 2013 | August 2014 |
| NCT01778348 | Completed | Phase 2 | Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting | December 2013 | May 2015 |
| NCT01835457 | Completed | N/A | Concentration/Meditation Limits Inflammation | February 2013 | July 2013 |
| NCT01917760 | Completed | Pharmacokinetics Study of Gamma-aminobutyric Acid | July 2013 | December 2014 | |
| NCT01953523 | Completed | N/A | Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions | September 2, 2013 | January 1, 2017 |
| NCT05666115 | Completed | N/A | Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot Study | January 2, 2023 | June 10, 2023 |
| NCT02129868 | Completed | N/A | Automated Closed-loop in Children and Adolescents With Type 1 Diabetes | April 2014 | April 2015 |
| NCT02280434 | Completed | Phase 1 | Phase 1 Study Accessing the Safety and Tolerability of CBP-307 | November 2014 | August 2015 |
| NCT02293161 | Completed | Phase 1 | Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers | November 11, 2014 | September 1, 2015 |
| NCT02417155 | Completed | N/A | Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study | November 2014 | October 2015 |
| NCT02510092 | Completed | N/A | Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment | July 2015 | March 2021 |
| NCT02516124 | Completed | EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients | December 2012 | March 2018 | |
| NCT02523131 | Completed | N/A | Home Testing of Day and Night Closed Loop With Pump Suspend Feature | May 2016 | March 2018 |
| NCT05218434 | Completed | Phase 1 | A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses | November 17, 2021 | December 3, 2022 |
| NCT02602977 | Completed | Early Phase 1 | the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia | October 2015 | March 2016 |
| NCT02644759 | Completed | Phase 1/Phase 2 | Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus | February 2014 | May 2018 |
| NCT05210530 | Completed | Phase 1 | An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D | January 24, 2022 | January 19, 2023 |
| NCT05148806 | Completed | Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | December 7, 2021 | December 30, 2022 | |
| NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
| NCT02824393 | Completed | Early Phase 1 | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria | March 3, 2017 | July 15, 2018 |
| NCT02899377 | Completed | N/A | A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts | November 18, 2016 | July 12, 2018 |
| NCT02925299 | Completed | N/A | Day and Night Closed-loop in Young People With Type 1 Diabetes | May 12, 2017 | August 27, 2020 |
| NCT03044873 | Completed | Phase 1 | Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin | February 2, 2017 | March 27, 2017 |
| NCT03114267 | Completed | Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis | January 6, 2012 | January 6, 2015 | |
| NCT03140137 | Completed | Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases | January 21, 2017 | January 4, 2018 | |
| NCT03173144 | Completed | Chronic Inflammatory Disease, Lifestyle and Treatment Response | September 21, 2017 | April 30, 2021 | |
| NCT03907540 | Completed | Phase 1 | Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 | April 5, 2019 | May 20, 2019 |
| NCT03956953 | Completed | Phase 1 | Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects | April 4, 2019 | September 25, 2019 |
| NCT04005456 | Completed | N/A | Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design | September 1, 2018 | December 31, 2022 |
| NCT00010335 | Completed | Phase 1 | Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders | November 2000 | May 2011 |
| NCT00010387 | Completed | Phase 2 | Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease | March 1999 | |
| NCT00035308 | Completed | Phase 3 | Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease | December 2002 | |
| NCT00039988 | Completed | N/A | Treatment of Multiple Sclerosis With Copaxone and Albuterol | November 2001 | November 2007 |
| NCT00048685 | Completed | Study of Oral Bacteria in Patients With Dry Mouth | November 2002 | August 2004 | |
| NCT00419419 | Completed | Phase 3 | Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon | December 2006 | |
| NCT00001330 | Completed | Study of Silicone-Associated Connective Tissue Diseases | November 1992 | October 2000 | |
| NCT04293718 | Completed | Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy | October 2011 | July 2019 | |
| NCT04274257 | Completed | Phase 2/Phase 3 | A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis | December 4, 2017 | November 5, 2019 |
| NCT00001768 | Completed | Phase 3 | Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) | October 1997 | June 2000 |
| NCT03901664 | Completed | Lymphocyte Sub-populations and Auto Immune Diseases | February 1, 2018 | April 1, 2018 | |
| NCT04007939 | Completed | Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC) | January 1, 2018 | December 31, 2022 | |
| NCT05069714 | Completed | Phase 3 | One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. | October 1, 2021 | September 30, 2022 |
| NCT03193177 | Completed | A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases | June 20, 2017 | December 31, 2018 | |
| NCT03199638 | Completed | N/A | Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes | April 1, 2016 | June 30, 2017 |
| NCT04872257 | Completed | N/A | Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo | September 14, 2021 | November 1, 2022 |
| NCT03266172 | Completed | Phase 1 | A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses | September 27, 2017 | November 21, 2018 |
| NCT04837651 | Completed | Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab | March 2, 2021 | July 1, 2021 | |
| NCT03305419 | Completed | Phase 1 | A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects | October 11, 2017 | October 15, 2018 |
| NCT03337165 | Completed | Phase 1 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | December 2016 | August 2019 |
| NCT03342495 | Completed | N/A | Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial | February 6, 2018 | September 7, 2021 |
| NCT03345004 | Completed | Phase 2 | Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes | December 20, 2017 | April 27, 2021 |
| NCT04818970 | Completed | N/A | Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients | May 21, 2021 | December 1, 2021 |
| NCT04818229 | Completed | Phase 1 | A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects | June 1, 2021 | March 30, 2022 |
| NCT03490539 | Completed | Disease-Modifying Treatments for Myasthenia Gravis | May 7, 2018 | January 31, 2021 | |
| NCT03492242 | Completed | Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction | February 1, 2018 | September 30, 2018 | |
| NCT03503747 | Completed | Investigating Genetic Risk for Type 1 Diabetes | April 25, 2018 | August 31, 2021 | |
| NCT03530995 | Completed | Phase 1 | Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers | April 9, 2018 | February 8, 2019 |
| NCT04805099 | Completed | Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease | November 1, 2020 | February 28, 2021 | |
| NCT03590613 | Completed | Phase 1 | Phase I Study of GSK2982772 in Japanese Healthy Male Participants | July 19, 2018 | September 26, 2018 |
| NCT04754607 | Completed | N/A | Effects of Low-Level Laser Therapy on Oxidative Stress Levels... | February 9, 2021 | June 30, 2022 |
| NCT03649412 | Completed | Phase 1 | A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 | September 26, 2018 | May 7, 2019 |
| NCT04691232 | Completed | Phase 1 | Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis | February 22, 2021 | May 22, 2023 |
| NCT04665232 | Completed | Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases | April 2014 | April 2017 | |
| NCT03736278 | Completed | Characteristics of Tuberculosis Infection in Rheumatic Disease | November 10, 2018 | September 24, 2019 | |
| NCT03778840 | Completed | Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab | May 29, 2019 | May 31, 2022 | |
| NCT04298749 | Completed | Phase 1 | Safety and Tolerability of GX-P1 in Healthy Male Volunteers | August 11, 2020 | June 7, 2021 |
| NCT05080907 | Enrolling by invitation | Collection and Distribution of Biospecimens for Novel Research | July 15, 2016 | January 2025 | |
| NCT04297592 | Enrolling by invitation | Phase 4 | Antibiotic Prophylaxis in High-Risk Arthroplasty Patients | June 11, 2020 | June 2025 |
| NCT05889806 | Enrolling by invitation | AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens) | May 10, 2023 | June 10, 2043 | |
| NCT02422875 | Enrolling by invitation | Comparative Autoantibody and Immunologic Cell Marker Study | August 2012 | August 2024 | |
| NCT05400954 | Enrolling by invitation | Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases | July 1, 2022 | June 1, 2025 | |
| NCT05238181 | Enrolling by invitation | Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis | January 1, 2022 | December 31, 2024 | |
| NCT06464679 | Not yet recruiting | Phase 1 | An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases | June 30, 2024 | June 30, 2026 |
| NCT03870828 | Not yet recruiting | Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study | March 18, 2019 | December 31, 2025 | |
| NCT03899298 | Not yet recruiting | Phase 1 | Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions | September 1, 2019 | March 20, 2029 |
| NCT04902807 | Not yet recruiting | Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation | June 2021 | December 2024 | |
| NCT05544448 | Not yet recruiting | N/A | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases | October 15, 2022 | April 15, 2023 |
| NCT05777499 | Not yet recruiting | N/A | MUSic Therapy In Complex Specialist Neurorehabilitation | March 2023 | September 2025 |
| NCT05842824 | Not yet recruiting | An Observational Study of Patients With Autoimmune Disease | August 1, 2024 | December 31, 2038 | |
| NCT05910840 | Not yet recruiting | N/A | Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care | November 1, 2023 | June 1, 2027 |
| NCT05915676 | Not yet recruiting | Role of LILRA3 in Ankylosing Spondylitis and Axial Psoriatic Patients | July 1, 2023 | July 30, 2024 | |
| NCT05965843 | Not yet recruiting | Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases | August 2023 | December 2024 | |
| NCT05969821 | Not yet recruiting | Clonal Hematopoiesis of Immunological Significance | September 2023 | September 2043 | |
| NCT05974683 | Not yet recruiting | N/A | Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period | August 1, 2023 | December 2025 |
| NCT06069583 | Not yet recruiting | N/A | Implementation of Support in the Care of Adults Living With Type 1 Diabetes | January 5, 2024 | January 5, 2028 |
| NCT06183190 | Not yet recruiting | GUT MICROBIOTA IN CHILDREN WITH AUTOIMMUNE LIVER DISEASE AND ITS EFFECT ON TREATMENT RESPONSE | December 25, 2023 | December 31, 2025 | |
| NCT06243159 | Not yet recruiting | Early Phase 1 | JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases | February 8, 2024 | December 31, 2026 |
| NCT06272084 | Not yet recruiting | Analysis of TPE Treatments With multiFiltratePRO | May 2024 | December 2024 | |
| NCT06350110 | Not yet recruiting | Phase 1/Phase 2 | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) | November 10, 2024 | December 28, 2025 |
| NCT06375993 | Not yet recruiting | Phase 1 | A Phase 1 Study of ADI-001 in Lupus Nephritis | June 2024 | December 2027 |
| NCT06382675 | Not yet recruiting | N/A | Clinical Performance of the New Plasma Filter PX2 in TPE Treatments | April 2024 | March 2025 |
| NCT06416267 | Not yet recruiting | Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) | August 2024 | December 2040 | |
| NCT06426316 | Not yet recruiting | N/A | The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. | May 15, 2024 | April 30, 2027 |
| NCT06435468 | Not yet recruiting | N/A | Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases | July 2024 | July 2034 |
| NCT04684602 | Recruiting | Phase 1/Phase 2 | Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions | July 9, 2020 | December 9, 2030 |
| NCT03651518 | Recruiting | Phase 2 | Personalized Therapies in Inflammatory Complex Disease | October 20, 2020 | November 2025 |
| NCT05383339 | Recruiting | Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases | November 29, 2022 | November 29, 2031 | |
| NCT05394922 | Recruiting | Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA) | August 23, 2022 | February 22, 2024 | |
| NCT05414890 | Recruiting | Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination | June 30, 2022 | June 30, 2024 | |
| NCT05459870 | Recruiting | Phase 1/Phase 2 | CAR-T Cells Targeting Autoimmune Diseases | July 31, 2022 | June 30, 2026 |
| NCT05545839 | Recruiting | N/A | Transition to Adulthood Through Coaching and Empowerment in Rheumatology | October 17, 2022 | April 2025 |
| NCT05565248 | Recruiting | Phase 1/Phase 2 | An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D | January 20, 2023 | August 2025 |
| NCT05586737 | Recruiting | Phase 2 | Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency | April 29, 2019 | December 2024 |
| NCT05670301 | Recruiting | N/A | Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases | September 28, 2022 | December 31, 2029 |
| NCT05678374 | Recruiting | Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease | October 1, 2019 | December 20, 2024 | |
| NCT05683990 | Recruiting | Phase 2 | Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes | November 14, 2023 | February 28, 2025 |
| NCT05726461 | Recruiting | N/A | Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China | February 11, 2023 | September 30, 2024 |
| NCT06278337 | Recruiting | X-linked Moesin Associated Immunodeficiency | August 12, 2021 | January 12, 2027 | |
| NCT05789017 | Recruiting | N/A | Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement | July 1, 2022 | December 31, 2024 |
| NCT05789030 | Recruiting | N/A | Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement | July 1, 2022 | December 30, 2024 |
| NCT05792176 | Recruiting | N/A | Ukulele Playing to Improve Cognition in People With Multiple Sclerosis: A Feasibility Study | March 27, 2023 | August 1, 2025 |
| NCT01758042 | Recruiting | N/A | Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders | November 2012 | July 2027 |
| NCT05831826 | Recruiting | Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China | June 1, 2020 | December 2024 | |
| NCT06279923 | Recruiting | Early Phase 1 | CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases | April 15, 2024 | February 1, 2027 |
| NCT05853835 | Recruiting | Phase 1 | First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 | October 30, 2023 | November 1, 2024 |
| NCT05875155 | Recruiting | Ovarian Tissue Cryopreservation for Fertility Preservation | January 13, 2011 | January 2031 | |
| NCT05883371 | Recruiting | IMPACT - AndHealth Autoimmune Research Registry | June 8, 2023 | May 22, 2028 | |
| NCT06283316 | Recruiting | Systemic Treatments for Alopecia Areata Registry | January 17, 2024 | December 31, 2099 | |
| NCT06291415 | Recruiting | Phase 1 | The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) | April 2, 2024 | November 2026 |
| NCT05958446 | Recruiting | Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women | April 14, 2022 | April 14, 2026 | |
| NCT06318533 | Recruiting | Early Phase 1 | A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases | March 13, 2024 | March 13, 2026 |
| NCT01351545 | Recruiting | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) | October 2011 | October 2041 | |
| NCT06339957 | Recruiting | Rheumatology Diet Study | March 1, 2024 | July 1, 2024 | |
| NCT06342713 | Recruiting | Phase 1 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 | June 3, 2024 | April 30, 2025 |
| NCT06019611 | Recruiting | N/A | Epidural Stimulation in Multiple Sclerosis | September 11, 2023 | September 2024 |
| NCT06054373 | Recruiting | The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases | July 27, 2023 | September 2023 | |
| NCT06417502 | Recruiting | Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry | April 29, 2022 | December 31, 2031 | |
| NCT06435897 | Recruiting | Phase 1/Phase 2 | Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells | May 15, 2024 | December 31, 2027 |
| NCT06208280 | Recruiting | Phase 1 | F01 in the Treatment of Autoimmune Diseases | January 9, 2024 | December 2025 |
| NCT06235580 | Recruiting | Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions | December 1, 2014 | January 1, 2031 | |
| NCT06428188 | Recruiting | Phase 1/Phase 2 | Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases | May 29, 2024 | December 28, 2026 |
| NCT03953768 | Recruiting | N/A | VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems | April 1, 2021 | December 14, 2026 |
| NCT04015596 | Recruiting | Phase 4 | Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS | October 20, 2020 | October 31, 2024 |
| NCT04078698 | Recruiting | N/A | Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine | September 5, 2019 | April 2026 |
| NCT03848962 | Recruiting | Collection and Distribution of Biospecimens for Novel Research Uses | June 30, 2016 | December 31, 2026 | |
| NCT04561557 | Recruiting | Early Phase 1 | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | September 22, 2020 | May 31, 2027 |
| NCT04656873 | Recruiting | Immuno-Oncology Database and Bioregistry | May 20, 2021 | April 2031 | |
| NCT04784364 | Recruiting | Biologics And Clinical Immunology Cohort at Sinai | March 3, 2021 | March 2026 | |
| NCT04786821 | Recruiting | N/A | Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis | June 23, 2022 | October 30, 2024 |
| NCT03540485 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis | November 29, 2019 | December 2024 |
| NCT03276923 | Recruiting | Maternal Autoimmune Disease Research Alliance (MADRA) Registry | January 1, 2018 | January 1, 2027 | |
| NCT04838171 | Recruiting | Prospective Study of White Blood Cells | March 24, 2021 | December 2024 | |
| NCT04890483 | Recruiting | N/A | tDCS in Post-Acute COVID-19 Patients With SARDs | May 17, 2021 | May 7, 2024 |
| NCT06248957 | Recruiting | SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION | January 1, 2024 | December 31, 2031 | |
| NCT04978948 | Recruiting | Study of STIM1 Membrane Expression | May 11, 2021 | May 2027 | |
| NCT05016700 | Recruiting | Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders | March 20, 2019 | December 31, 2033 | |
| NCT05085418 | Recruiting | Early Phase 1 | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis | November 5, 2021 | November 5, 2024 |
| NCT05085431 | Recruiting | Early Phase 1 | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome | November 5, 2021 | November 5, 2024 |
| NCT05085444 | Recruiting | Early Phase 1 | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma | October 8, 2021 | October 8, 2024 |
| NCT05139706 | Recruiting | Montreal Immune-Related Adverse Events (MIRAE) Study | January 21, 2020 | January 2030 | |
| NCT02682511 | Recruiting | Phase 2 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | January 2017 | December 2025 |
| NCT05168215 | Recruiting | Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. | January 1, 2022 | June 1, 2024 | |
| NCT05239702 | Recruiting | Early Phase 1 | Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases | February 28, 2022 | December 1, 2024 |
| NCT05293899 | Recruiting | The Pathogenesis of Depression - Possible Autoimmune Mechanisms | February 15, 2022 | April 15, 2026 | |
| NCT05418101 | Terminated | Phase 1 | A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease) | April 28, 2022 | February 15, 2024 |
| NCT03183869 | Terminated | Phase 2 | Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients | August 24, 2017 | January 25, 2019 |
| NCT03656627 | Terminated | Phase 1 | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | June 27, 2019 | March 18, 2021 |
| NCT03656640 | Terminated | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | November 23, 2016 | December 9, 2019 | |
| NCT04870411 | Terminated | Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics | May 12, 2021 | March 13, 2022 | |
| NCT03444805 | Unknown status | EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2) | July 1, 2019 | March 30, 2023 | |
| NCT02203682 | Unknown status | Phase 2 | Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy | July 2014 | July 2022 |
| NCT03644069 | Unknown status | Phase 2 | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) | August 6, 2018 | September 2019 |
| NCT04789993 | Unknown status | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up | March 15, 2021 | April 30, 2021 | |
| NCT00742300 | Unknown status | Phase 1/Phase 2 | Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases | January 1998 | |
| NCT03456206 | Unknown status | Chronic Inflammatory Disease, Lifestyle and Risk of Disease | November 10, 2018 | May 1, 2023 | |
| NCT02404298 | Unknown status | N/A | Transcriptome Analysis of the Peripheral Blood in CIDP | February 2015 | September 2018 |
| NCT04127747 | Unknown status | Phase 4 | Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus | August 18, 2020 | July 1, 2023 |
| NCT04155086 | Unknown status | N/A | "Circulating Fetal DNA, Pregnancy And Immune Diseases" | December 2019 | June 2022 |
| NCT01579110 | Unknown status | Phase 2 | Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. | April 2012 | April 2016 |
| NCT03885375 | Unknown status | Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients | April 1, 2018 | April 30, 2020 | |
| NCT02261662 | Unknown status | N/A | Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection | June 2014 | November 2014 |
| NCT04698824 | Unknown status | Hypnosis in Internal Medecine | June 2021 | October 2021 | |
| NCT03793270 | Unknown status | Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis | January 3, 2019 | August 20, 2020 | |
| NCT01981785 | Unknown status | Investigation of Immune Disorders and Deficiencies | December 2012 | December 2018 | |
| NCT04353609 | Unknown status | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases | April 18, 2020 | December 2020 | |
| NCT05026892 | Unknown status | Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases | August 2021 | July 2022 | |
| NCT05030779 | Unknown status | Early Phase 1 | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus | September 10, 2021 | September 10, 2022 |
| NCT05042271 | Unknown status | PK of Meropenem in Patients on Plasma Exchange | January 1, 2020 | December 31, 2022 | |
| NCT03180190 | Unknown status | Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine) | June 28, 2017 | July 28, 2018 | |
| NCT04039763 | Unknown status | N/A | RT-CGM in Young Adults at Risk of DKA | September 3, 2020 | June 30, 2022 |
| NCT04041544 | Unknown status | Phase 1 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject | August 27, 2019 | August 2020 |
| NCT03790293 | Unknown status | Phase 3 | Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial | December 2019 | December 2019 |
| NCT02704338 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis | April 2016 | October 2018 |
| NCT05116215 | Unknown status | Phase 1 | To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement | August 13, 2021 | August 12, 2022 |
| NCT04096222 | Unknown status | Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients | June 29, 2021 | March 28, 2023 | |
| NCT04124861 | Unknown status | N/A | Withdraw Drug in Stable IgG4-Related Disease | June 23, 2020 | June 30, 2023 |
| NCT00862693 | Unknown status | Phase 4 | Calcitriol in the Treatment of Immunoglobulin A Nephropathy | March 2009 | March 2011 |
| NCT05196295 | Unknown status | Phase 1 | To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement. | January 11, 2022 | July 30, 2022 |
| NCT03239600 | Withdrawn | Phase 2 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) | September 19, 2017 | October 12, 2017 |
| NCT02586831 | Withdrawn | Phase 1/Phase 2 | Diabetes Islet Preservation Immune Treatment | January 2025 | December 2029 |
| NCT02123147 | Withdrawn | Examining the Immunological Process of Autoimmune Patients | July 2014 | August 2016 | |
| NCT00777400 | Withdrawn | Phase 1/Phase 2 | Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells | December 2008 | April 2009 |
| NCT01453764 | Withdrawn | N/A | Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis | April 2016 | April 2019 |
| NCT03884400 | Withdrawn | Distribution of Biospecimens From Biorepositories/Biobanks for Research Use | January 1, 2021 | March 1, 2026 | |
| NCT02671188 | Withdrawn | Phase 1 | A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis | June 1, 2018 | August 9, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001327